Why Hair Loss Progresses Even With Normal Testosterone — Blood Hormones vs. Hair Follicle Androgen Sensitivity2026.06.29

“My blood test showed testosterone in the normal range, so why is my hair still thinning?” This is one of the most common questions Dr. Moriwaki hears in our AGA clinic. The seemingly paradoxical fact that hair loss progresses even when male hormone levels are perfectly average is best explained by a concept called hair follicle androgen sensitivity. In this article, we organize the medical reasons why blood hormone values do not always match what is happening at the scalp, and how stem cell conditioned media fits into a modern AGA treatment plan.

Blood testosterone does not predict AGA linearly

AGA is often misunderstood as a disease of “men with too much testosterone,” but clinical reality is more nuanced. Many patients with free testosterone well within — or even below — the reference range continue to lose hair from the crown and frontal hairline.

“Normal hormone levels” does not mean “safe from AGA”

A blood draw measures the total amount of male hormone circulating in the bloodstream. What is actually thinning, however, is the hair follicle in the scalp — and a serum number cannot show how that hormone is being received locally. In a person with high receptor sensitivity, even a small concentration of androgens can trigger a strong follicular response. Conversely, someone with low sensitivity may show slow-moving thinning despite higher hormone values.

Individual variation is driven by the receiving side

It is not unusual for siblings raised in the same household, eating the same diet, to have very different rates of hair loss. The variation almost always lies on the receiving side — the follicle — rather than in the amount of hormone being produced. To understand AGA, the concept of hair follicle androgen sensitivity is essential.

What is hair follicle androgen sensitivity?

Hair follicle androgen sensitivity refers to how strongly the cells of the hair follicle — especially the dermal papilla cells — receive and respond to signals from male hormones, primarily DHT (dihydrotestosterone).

Androgen receptor (AR) expression and gene polymorphism

Dermal papilla cells carry androgen receptors (AR) that bind male hormones. AR expression varies significantly by scalp region and by individual: dermal papilla cells in the frontal scalp and crown express more AR than those at the occipital region. This anatomical difference explains the classic AGA pattern in which the occipital hair persists while the frontal hair thins first.

In addition, the CAG repeat length within the AR gene has been reported to affect receptor activity. Shorter CAG repeats are associated with stronger receptor activity and higher AGA risk, indicating that hair follicle androgen sensitivity has a clear genetic basis.

It is local DHT that miniaturizes the follicle

When testosterone circulating in the blood reaches the scalp follicle, the enzyme 5α-reductase converts it locally into the more potent DHT. DHT then binds to AR, shortening the anagen phase and progressively miniaturizing the follicle. What matters is that this cascade is determined not by your systemic hormone profile, but by local DHT concentration and AR sensitivity inside the follicle.

For AGA treatment guidance, please refer to the Japanese Dermatological Association, which publishes systematic guidelines on male and female pattern hair loss.

Treatment strategy centered on hair follicle androgen sensitivity

For AGA — which cannot be captured by blood numbers alone — strategies must intervene directly in what is happening locally at the follicle.

Oral medications suppress DHT production

5α-reductase inhibitors such as finasteride and dutasteride suppress the conversion of testosterone into DHT within the follicle. Local DHT then falls, and even patients with high sensitivity experience reduced stimulus and slower miniaturization. However, this approach is fundamentally about “reducing the attack” — it does not directly drive regeneration of damaged follicles.

Stem cell conditioned media restores the follicular micro-environment

While the underlying constitution of hair follicle androgen sensitivity cannot be rewritten, restoring the surrounding environment of miniaturized follicles and reactivating dermal papilla cells is realistic. Stem cell conditioned media contains a complex mix of growth factors, cytokines and exosomes that support dermal papilla proliferation and peri-follicular angiogenesis — acting on what we describe as the follicle’s regenerative switch.

At AVAN TOKYO we recommend pairing oral medication that suppresses DHT production with stem cell conditioned media delivered through Morpheus8 drug delivery to recondition the micro-environment. By approaching from both the offensive and defensive sides, even patients with high hair follicle androgen sensitivity can realistically aim for long-term volume maintenance.

For more articles on hair regenerative medicine, please also see our collection of related columns.

Summary

Hair loss can progress even when blood testosterone is normal. Behind this fact lie two key elements: local DHT concentration and receptor sensitivity within the follicle. Individual variation in AGA is determined more by the receiving side than by the absolute hormone amount. Combining oral DHT-suppressing medication with stem cell conditioned media that restores the follicular environment makes long-term maintenance and improvement achievable, even for highly sensitive patients. Rather than postponing treatment because “the bloodwork looks fine,” it is far more productive to face the changes actually happening at the scalp early on.

──────────────

Medical Supervisor: Shin Moriwaki, MD

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate (US Medical Licensure Qualification)

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries via DM / LINE / Website / Phone.